Literature DB >> 4102232

Au-H.A.A. in sera of diabetic patients.

K Madaliński, W J Brzosko, B Malczewski, A Czyzyk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4102232     DOI： 10.1016/s0140-6736(71)92708-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Reduced protection against hepatitis B virus following vaccination in patients with type 1 (insulin-dependent) diabetes.

Authors:  P Pozzilli; P Arduini; N Visalli; J Sutherland; M Pezzella; C Galli; S G Corradini; L Biasio; E A Gale; D Andreani
Journal:  Diabetologia       Date:  1987-10       Impact factor: 10.122

2.  Hyporesponsiveness to intradermal administration of hepatitis B vaccine in insulin dependent diabetes mellitus.

Authors:  S Li Volti; M Caruso-Nicoletti; F Biazzo; A Sciacca; G Mandarà; M Mancuso; F Mollica
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

3.  Australia antigen in diabetic subjects.

Authors:  S Marigo; G Canova; F Bernardi; G Faccini; A Coli; R Russo
Journal:  Acta Diabetol Lat       Date:  1976 May-Aug

4.  Role of hepatitis B virus infection in chronic liver disease of diabetic patients: a case-control study.

Authors:  G Colloredo Mels; G Bettale; G Bellati; M Guanziroli; L Tiraboschi; G Angeli; G Idéo
Journal:  Acta Diabetol Lat       Date:  1986 Jan-Mar

5.  Antibody levels against hepatitis B virus after hepatitis B vaccination in Egyptian diabetic children and adolescents.

Authors:  Heba Elrashidy; Ashraf Elbahrawy; Gamal El-Didamony; Mohamed Mostafa; Nilly M George; Ahmed Elwassief; Abdel-Gawad Saeid Mohamed; Amr Elmestikawy; Mohamed Hanafy Morsy; Alaa Hashim; Mohamed Ali Abdelbasseer
Journal:  Hum Vaccin Immunother       Date:  2013-06-20       Impact factor: 3.452
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.